Top Markets
Coin of the day
Wuhan General Group (China), Inc. Wuhan General Group (China), Inc.

Wuhan General Group (China), Inc.

WUHN
Rang in Aktien #41554
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company,... Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.
Aktienkurs
$0.0003
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$16.55K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
200.00%
Land
ZA
Handel Wuhan General Group (China), Inc. (WUHN)

Kategorie

Dividendenrendite-Verlauf für Wuhan General Group (China), Inc. (WUHN)
Dividendenrendite (TTM) von Wuhan General Group (China), Inc. (Aktienkürzel: WUHN) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Wuhan General Group (China), Inc. (WUHN) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber